Benign Prostatic Hyperplasic Devices Market Forecast to 2028

Benign Prostatic Hyperplasic Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Resectoscopes, Urology Lasers, Radiofrequency Ablation Devices, Prostatic Stents, and Implants), Procedure Type (Transurethral Microwave Therapy, Transurethral Resection of the Prostate, Transurethral Needle Ablation of the Prostate, Laser Surgery, Urolift Surgery, and Others), and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Geography

Report Code : TIPRE00025704 | Region : Global | Industry : Medical Device | Published Date : 14/Jul/2022

The global benign prostatic hyperplasic devices market is expected to US$ 2,078.78 million in 2021 to US$ 3,467.31 million by 2028; it is expected to grow with a CAGR of 7.6% from 2022 to 2028.

An increase in the prevalence of benign prostatic hyperplasia along with growing risk factors and a rise in investments, funds, and grants for research in BPH treatment boost the global benign prostatic hyperplasic devices market growth.

Benign prostatic hyperplasia (BPH) is a prostate enlargement caused by excessive cell growth in the prostate. BPH is a benign (non-cancerous) prostate condition. Non-cancerous conditions are not usually fatal and do not spread (metastasize) to other body parts. BPH doesn't raise the risk of prostate cancer; unless it manifests symptoms, BPH isn't considered a health issue. Almost all men will have some prostate growth by the age of 70. Getting older, having more belly fat (also known as abdominal obesity), and not getting enough exercise to raise the risk of developing BPH.

Players operating in the benign prostatic hyperplasic devices industry focus on investing high amounts in the development of advanced surgical technologies as alternatives to conventional techniques. Advanced devices enabled with new technologies help provide immediate relief and reduce morbidity.

• In January 2022, ProVerum, a start-up supported by EIT Health, received US$ 31.22 million in Series A funding from Gilde Healthcare, Lightstone Ventures, and Atlantic Bridge. ProVerum, an Irish company, has developed ProVee, a cutting-edge treatment solution for men with symptomatic BPH. The company aims to market its innovative device in the US and Europe with the help of recent funding.

• In June 2021, Zenflow, Inc., a medical device company developing a minimally invasive treatment for urinary obstruction caused by BPH or enlarged prostate, declared the completion of its Series B funding round with a total of US$ 24 million. The investment was led by Invus Opportunities and included participation from Medical Technology Venture Partners, F-Prime Capital, CloudStone Capital, Astia Angels, Golden Seeds, SV Tech Ventures, etc.

• In June 2021, Procept Biorobotics raised US$ 85 million to commercialize the AquaBeam system as a global BPH treatment. With this product, the company intends to make an impact with its water-based robotic technology in the field of prostate surgery. The series G financing was led by Fidelity Management & Research Company, with additional backing from T. Rowe Price Associates, CPMG, Perceptive Advisors, Viking Global Investors, and Duquesne Family Office.

• In July 2019, Medeon Biodesign, Inc, a publicly traded Taiwan medical device company, announced that it recently led and closed an investment in Prodeon. Prodeon is a Taiwan-based company offering a simple, office-based treatment option for patients who need quick relief from LUTS caused due to BPH.

• In April 2018, ProVerum Medical closed a US$ 4.2 million seed investment, with Atlantic Bridge University Fund leading the investment round. With this investment, the company aims to commence its first human trials of its product for BPH treatment. This product includes a nitinol implant to dilate the prostatic urethra without altering the structure of the prostate anatomy. The nitinol implant can be manufactured to a small size to simplify the process of implantation through a 10–15-minute long minimally invasive surgery.

• In February 2018, Zenflow, a medical device company based in San Francisco, California, announced a US$ 31.4 million Series A investment round for further advancements in its minimally invasive technique for treating BPH or an enlarged prostate.

Product-Based Insights

Based on the product, the benign prostatic hyperplasic devices market is segmented into resectoscopes, radiofrequency ablation devices, urology lasers, prostatic stents, and implants. The resectoscopes segment is likely to hold the largest market share in 2022. However, the urology lasers segment is anticipated to register the highest CAGR during the forecast period due to the high demand by physicians and the rising initiatives of market players in the launch and product expansion.

Procedure Type Insights

Based on procedure type, the benign prostatic hyperplasic devices market is segmented into transurethral microwave therapy, transurethral resection of the prostate, transurethral needle ablation of the prostate, laser surgery, urolift surgery, and others. In 2022, the transurethral resection of the prostate segment is likely to hold the market's largest share. Furthermore, the same segment is expected to witness growth in its demand at the fastest CAGR from 2022 to 2028, owing to its visual, hands-on access to the prostate, ability to the immediate removal of excess tissue, the ability of transurethral resection of the prostate (TURP) to combine with other procedures.

End User-Based Insights

Based on end user, the benign prostatic hyperplasic devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment is likely to hold the largest share of the market. Moreover, the clinics segment is expected to witness growth in its demand at the fastest CAGR from 2022 to 2028, owing to an increase in the number of clinics at a lower cost for treatment, easy accessibility, and flexibility with the short waiting time.

National Center for Biotechnology Information (NCBI), National Library of Medicine, Indiana University School of Medicine, Centers for Disease Control and Prevention (CDC), Canadian Risk Factor Atlas (CRFA), World Bank, Urology Foundation, International Diabetes Federation (IDF), National Statistics Institute (INE), National Medica Device Promotion Council, International Trade Administration, Department of Emergency Medicine are among the primary and secondary sources referred to while preparing the report on the benign prostatic hyperplasic devices market.

Increase in Prevalence of Benign Prostatic Hyperplasia along with Growing Risk Factors to Drive Global Benign Prostatic Hyperplasic Devices Market

According to our new research study on "Benign Prostatic Hyperplasic Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Procedure Type, End User, and Geography" the market is expected to grow from US$ 2,078.78 million in 2021 to US$ 3,467.31 million by 2028; it is estimated to grow at a CAGR of 7.6% from 2022 to 2028. The rise in the prevalence of benign prostatic hyperplasia amongst men and increasing risk factors is driving the growth of the benign prostatic hyperplasic devices market. Moreover, the rise in investments, funds, and grants for research in BPH treatment is boosting the market growth. However, less awareness about prostate health among men is hampering the market's growth.

Benign prostatic hyperplasia (BPH) is a prostate enlargement caused by excessive cell growth in the prostate. BPH is a non-cancerous prostate condition that is not usually fatal. As it is benign, the condition does not involve metastasis to other body parts. BPH is not associated with the risk of prostate cancer; moreover, unless it manifests symptoms, BPH is not considered a health issue. Almost all men are likely to have some prostate growth by age 70. Aging, abdominal obesity, and lack of physical exercise raise the risk of developing BPH.

According to the National Center for Biotechnology Information (NCBI), BPH is one of the most common disorders in older men and the leading cause of lower urinary tract symptoms (LUTS). After the age of 40, the prevalence of BPH rises, reaching a peak of 60% by the age of 90. According to autopsy studies, the histological prevalence of BPH is 8%, 50%, and 80% in the fourth, sixth, and ninth decades of a man's life, respectively. Old age has also been a risk factor for the onset and progression of clinical BPH in observational studies conducted in Europe, the US, and Asia. According to statistics from the Krimpen and Baltimore Longitudinal Study of Aging, the prostate grows at a rate of 2.0% to 2.5% per year in older men. Continued prostate enlargement is a risk factor for developing LUTS, and larger prostates are associated with a benign prostatic enlargement (BPE), which triggers the risk of developing clinical BPH and urine incontinence.

According to NCBI data, increased adiposity is found to have a positive correlation with prostate volume. In numerous study groups, body weight, body mass index (BMI), and waist circumference have been seen to have a positive correlation with prostate volume. Additionally, epidemiological data shows obesity may raise the necessity of BPH surgery and initiating BPH treatment.

According to the American Journal of Men's Health (AJMH), in 2019, globally, there were 11.26 million new cases and 1.86 million YLD due to BPH in 2019. The incidence of BPH increased by 105.7%, and YLD increased by 110.6% worldwide during 1990–2019. The absolute incidence and YLD numbers increased considerably worldwide during this period, primarily due to population increase and aging. Therefore, the rising prevalence of benign prostatic hyperplasia and growing risk factors drive the growth of the benign prostatic hyperplasic devices market.

KARL STORZ SE & Co., KG; Richard Wolf GmbH; Olympus Corporation; Urologix, LLC.; Boston Scientific Corporation; Butterfly; TELEFLEX Incorporated; OmniGuide Holdings, Inc.; Convergent Laser Technologies; ProArc; and Olympus Corporation are a few leading companies operating in the benign prostatic hyperplasic devices market.

Benign Prostatic Hyperplasic Devices Market, by Region, 2021 (%)

Source: The Insight Partners Analysis

Based on product, the benign prostatic hyperplasic devices market is segmented into resectoscopes, urology laser, radiofrequency ablation devices, prostatic stents, and implants. Based on procedure type, the market is segmented into transurethral microwave therapy, transurethral resection of the prostate, transurethral needle ablation of the prostate, laser surgery, urolift surgery, and others. Based on end user, the market is segmented into hospitals, clinics, ambulatory surgical centers, and others. By geography, the benign prostatic hyperplasic devices market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Benign Prostatic Hyperplasic Devices Market – By Product

1.3.2 Global Benign Prostatic Hyperplasic Devices Market – By Procedure Type

1.3.3 Global Benign Prostatic Hyperplasic Devices Market – By End User

1.3.4 Global Benign Prostatic Hyperplasic Devices Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Benign Prostatic Hyperplasic Devices Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East And Africa PEST Analysis

4.2.5 South And Central America PEST Analysis

4.3 Experts Opinion

5. Benign Prostatic Hyperplasic Devices Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Benign Prostatic Hyperplasia along with Growing Risk Factors

5.1.2 Rise in Investments, Funds, and Grants for Research in BPH Treatment

5.2 Market Restraints

5.2.1 Low Awareness of Prostate Health Among Men

5.3 Market Opportunities

5.3.1 Emerging Markets

5.4 Future Trends

5.4.1 Product Approvals and Launches

5.5 Impact Analysis

6. Benign Prostatic Hyperplasic Devices Market – Global Analysis

6.1 Global Benign Prostatic Hyperplasic Devices Market Revenue Forecast and Analysis

6.2 Global Benign Prostatic Hyperplasic Devices Market, By Geography - Forecast and Analysis

6.3 Global Benign Prostatic Hyperplasic Devices Market – Market Potential Analysis, By Region

6.4 Company Analysis

6.4.1 Market Positioning of Key Players

6.4.2 Comparative Company Analysis

6.5 Growth Strategy Analysis

6.6 Performance of Key Players

6.6.1 Olympus Corporation

6.6.2 Butterfly Medical

7. Global Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028 – by Product

7.1 Benign Prostatic Hyperplasic Devices Market Revenue Share, by Product (2022 and 2028)

7.2 Resectoscopes

7.2.1 Overview

7.2.2 Resectoscopes: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

7.3 Urology Lasers

7.3.1 Overview

7.3.2 Urology Lasers: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Radiofrequency Ablation Devices

7.4.1 Overview

7.4.2 Radiofrequency Ablation Devices: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Prostatic Stents

7.5.1 Overview

7.5.2 Prostatic Stents: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Implants

7.6.1 Overview

7.6.2 Implants: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

8. Global Benign Prostatic Hyperplasic Devices Market Analysis and Forecast to 2028 - by Procedure Type

8.1 Benign Prostatic Hyperplasic Devices Market Revenue Share, by Procedure Type (2022 and 2028)

8.2 Transurethral Microwave Therapy

8.2.1 Overview

8.2.2 Transurethral Microwave Therapy: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Transurethral Resection of the Prostate

8.3.1 Overview

8.3.2 Transurethral Resection of the Prostate: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Transurethral Needle Ablation of the Prostate

8.4.1 Overview

8.4.2 Transurethral Needle Ablation of the Prostate: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Laser Surgery

8.5.1 Overview

8.5.2 Laser Surgery: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

8.6 UroLift Surgery

8.6.1 Overview

8.6.2 UroLift Surgery: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Others

8.7.1 Overview

8.7.2 Others: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

9. Global Benign Prostatic Hyperplasic Devices Market Analysis and Forecast to 2028 – by End User

9.1 Overview

9.2 Benign Prostatic Hyperplasic Devices Market Revenue Share, by End User (2022 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Million)

9.4 Clinics

9.4.1 Overview

9.4.2 Clinics Market Revenue and Forecast to 2028 (US$ Million)

9.5 Ambulatory Surgical Centers

9.5.1 Overview

9.5.2 Ambulatory Surgical Centers Market Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

10. Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 – Geographical Analysis

10.1 North America: Benign Prostatic Hyperplasic Devices Market

10.1.1 Overview

10.1.2 North America: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3 North America: Benign Prostatic Hyperplasic Devices Market, by Product, 2019–2028 (US$ Million)

10.1.4 North America: Benign Prostatic Hyperplasic Devices Market, by Procedure Type, 2019–2028 (US$ Million)

10.1.5 North America: Benign Prostatic Hyperplasic Devices Market, by End User, 2019–2028 (US$ Million)

10.1.6 North America: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)

10.1.6.1 US: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.1 Overview

10.1.6.1.2 US: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.3 US: Benign Prostatic Hyperplasic Devices Market, by Product, 2019–2028 (US$ Million)

10.1.6.1.4 US: Benign Prostatic Hyperplasic Devices Market, by Procedure Type, 2019–2028 (US$ Million)

10.1.6.1.5 US: Benign Prostatic Hyperplasic Devices Market, by End User, 2019–2028 (US$ Million)

10.1.6.2 Canada: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.1 Overview

10.1.6.2.2 Canada: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.3 Canada: Benign Prostatic Hyperplasic Devices Market, by Product, 2019–2028 (US$ Million)

10.1.6.2.4 Canada: Benign Prostatic Hyperplasic Devices Market, by Procedure Type, 2019–2028 (US$ Million)

10.1.6.2.5 Canada: Benign Prostatic Hyperplasic Devices Market, by End User, 2019–2028 (US$ Million)

10.1.6.3 Mexico: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.1 Overview

10.1.6.3.2 Mexico: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.3 Mexico: Benign Prostatic Hyperplasic Devices Market, by Product, 2019–2028 (US$ Million)

10.1.6.3.4 Mexico: Benign Prostatic Hyperplasic Devices Market, by Procedure Type, 2019–2028 (US$ Million)

10.1.6.3.5 Mexico: Benign Prostatic Hyperplasic Devices Market, by End User, 2019–2028 (US$ Million)

10.2 Europe: Benign Prostatic Hyperplasic Devices Market

10.2.1 Overview

10.2.2 Europe: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.2.3 Europe: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)

10.2.4 Europe: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)

10.2.5 Europe: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.6 Europe: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)

10.2.6.1 UK: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.1 Overview

10.2.6.1.2 UK: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.3 UK: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.4 UK: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.5 UK: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2 Germany: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.1 Overview

10.2.6.2.2 Germany: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.3 Germany: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.4 Germany: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.5 Germany: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3 France: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.1 Overview

10.2.6.3.2 France: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.3 France: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.4 France: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.5 France: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4 Italy: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.1 Overview

10.2.6.4.2 Italy: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.3 Italy: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.4 Italy: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.5 Italy: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5 Spain: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.1 Overview

10.2.6.5.2 Spain: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.3 Spain: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.4 Spain: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.5 Spain: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6 Rest of Europe: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.1 Overview

10.2.6.6.2 Rest of Europe: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.3 Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.4 Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.5 Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.3 Asia Pacific Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028

10.3.1 Overview

10.3.2 Asia Pacific Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.3.3 Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

10.3.4 Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

10.3.5 Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)

10.3.6 Asia Pacific: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)

10.3.6.1 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.1.1 Overview

10.3.6.1.2 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.1.3 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

10.3.6.1.4 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

10.3.6.1.5 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)

10.3.6.2 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.2.1 Overview

10.3.6.2.2 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.2.3 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

10.3.6.2.4 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

10.3.6.2.5 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)

10.3.6.3 India Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.3.1 Overview

10.3.6.3.2 India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.3.3 India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

10.3.6.3.4 India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

10.3.6.3.5 India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)

10.3.6.4 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.4.1 Overview

10.3.6.4.2 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.4.3 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

10.3.6.4.4 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

10.3.6.4.5 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)

10.3.6.5 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.5.1 Overview

10.3.6.5.2 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.5.3 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

10.3.6.5.4 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

10.3.6.5.5 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)

10.3.6.6 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.6.1 Overview

10.3.6.6.2 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.6.3 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

10.3.6.6.4 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

10.3.6.6.5 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)

10.4 Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028

10.4.1 Overview

10.4.2 Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.4.3 Middle East & Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

10.4.4 Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

10.4.5 Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By End User (US$ Million)

10.4.6 Middle East & Africa: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)

10.4.6.1 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.4.6.1.1 Overview

10.4.6.1.2 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.4.6.1.3 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

10.4.6.1.4 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)

10.4.6.1.5 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By End User (US$ Million)

10.4.6.2 South Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.4.6.2.1 Overview

10.4.6.2.2 South Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.4.6.2.3 South Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

10.4.6.2.4 South Africa: Metabolomics Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)

10.4.6.2.5 South Africa: Metabolomics Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)

10.4.6.3 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.4.6.3.1 Overview

10.4.6.3.2 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.4.6.3.3 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

10.4.6.3.4 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)

10.4.6.3.5 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By End User (US$ Million)

10.4.6.4 Rest of Middle East and Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.4.6.4.1 Overview

10.4.6.4.2 Rest of Middle East and Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.4.6.4.3 Rest of Middle East & Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

10.4.6.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)

10.4.6.4.5 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast To 2028, By End User (US$ Million)

10.5 South And Central America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028

10.5.1 Overview

10.5.2 South and Central America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.5.3 South and Central America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

10.5.4 South and Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

10.5.5 South and Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)

10.5.6 South and Central America: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)

10.5.6.1 Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.1 Overview

10.5.6.1.2 Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.3 Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

10.5.6.1.4 Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)

10.5.6.1.5 Brazil: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.5.6.2 Argentina Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.1 Overview

10.5.6.2.2 Argentina Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.3 Argentina: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

10.5.6.2.4 Argentina: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)

10.5.6.2.5 Argentina: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.5.6.3 Rest of South and Central America: Benign Prostatic Hyperplasic Devices Market– Revenue and Forecast to 2028 (USD Mn)

10.5.6.3.1 Overview

10.5.6.3.2 Rest of South and Central America: Benign Prostatic Hyperplasic Devices Market– Revenue and Forecast to 2028 (USD Mn)

10.5.6.3.3 Rest of South & Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

10.5.6.3.4 Rest of South & Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)

10.5.6.3.5 Rest of South and Central America: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Benign Prostatic Hyperplasic Devices Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment of COVID-19 Pandemic

11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic

11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Benign Prostatic Hyperplasic Devices Market – Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Benign Prostatic Hyperplasia Devices Market

12.3 Inorganic Growth Strategies

12.4 Organic Growth Strategies

13. Company Profiles

13.1 KARL STORZ SE & Co. KG

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Richard Wolf GmbH

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Olympus Corporation

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Urologix, LLC.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Boston Scientific Corporation

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Butterfly

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Teleflex Incorporated

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 OmniGuide Holdings, Inc.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Convergent Laser Technologies

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 ProArc

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms for Benign Prostatic Hyperplasia Devices Market

LIST OF TABLES.

Table 1. North America Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 2. North America Benign Prostatic Hyperplasic Devices Market, by Procedure Type– Revenue and Forecast to 2028 (US$ Million)

Table 3. North America Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 4. US Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)

Table 5. US Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)

Table 6. US Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7. Canada Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)

Table 8. Canada Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)

Table 9. Canada Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 10. Mexico Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)

Table 11. Mexico Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)

Table 12. Mexico Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13. Europe: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)

Table 14. Europe: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)

Table 15. Europe: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 16. UK: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)

Table 17. UK: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)

Table 18. UK: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 19. Germany: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)

Table 20. Germany: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)

Table 21. Germany: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 22. France: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)

Table 23. France: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)

Table 24. France: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 25. Italy: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)

Table 26. Italy: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)

Table 27. Italy: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 28. Spain: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)

Table 29. Spain: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)

Table 30. Spain: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 31. Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by Product– Revenue and Forecast to 2028 (US$ Million)

Table 32. Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by Procedure Type – Revenue and Forecast to 2028 (US$ Million)

Table 33. Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 34. Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million).

Table 35. Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

Table 36. Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 37. China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

Table 38. China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

Table 39. China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 40. Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

Table 41. Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

Table 42. Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 43. India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

Table 44. India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

Table 45. India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 46. South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

Table 47. South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

Table 48. South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 49. Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

Table 50. Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

Table 51. Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 52. Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

Table 53. Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

Table 54. Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 55. Middle East & Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

Table 56. Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

Table 57. Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 58. Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

Table 59. Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

Table 60. Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 61. South Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

Table 62. South Africa: Metabolomics Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

Table 63. South Africa: Metabolomics Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

Table 64. UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

Table 65. UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

Table 66. UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 67. Rest of Middle East & Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

Table 68. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

Table 69. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 70. South and Central America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

Table 71. South and Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

Table 72. South and Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 73. Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

Table 74. Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

Table 75. Brazil: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 76. Argentina: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

Table 77. Argentina: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

Table 78. Argentina: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 79. Rest of South & Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)

Table 80. Rest of South & Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)

Table 81. Rest of South and Central America: Benign Prostatic Hyperplasic Devices Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 82. Recent Inorganic Growth Strategies in the Benign Prostatic Hyperplasia Devices Market

Table 83. Recent Organic Growth Strategies in the Benign Prostatic Hyperplasia Devices Market

Table 84. Glossary of Terms

LIST OF FIGURES.

Figure 1. Benign Prostatic Hyperplasic Devices Market Segmentation

Figure 2. Benign Prostatic Hyperplasic Devices Market, By Region

Figure 3. Global Benign Prostatic Hyperplasic Devices Market Overview

Figure 4. Resectoscopes Segment Held Largest Share of Product Segment in Benign Prostatic Hyperplasic Devices Market

Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Benign Prostatic Hyperplasic Devices Market, by Geography (US$ Million)

Figure 7. Global Benign Prostatic Hyperplasic Devices Market- Leading Country Markets (US$ Million)

Figure 8. Global Benign Prostatic Hyperplasic Devices Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia Pacific: PEST Analysis

Figure 12. Middle East And Africa: PEST Analysis

Figure 13. South And Central America: PEST Analysis

Figure 14. Experts Opinion

Figure 15. Global Benign Prostatic Hyperplasic Devices Market – Revenue Forecast and Analysis – 2020-2028

Figure 16. Global Benign Prostatic Hyperplasic Devices Market – By Geography Forecast and Analysis – 2022- 2028

Figure 17. Global Benign Prostatic Hyperplasic Devices Market – Market Potential Analysis, By Region

Figure 18. Market Positioning of Key Players In Global Benign Prostatic Hyperplasic Devices Market

Figure 19. Global Benign Prostatic Hyperplasic Devices Market – Comparative Company Analysis

Figure 20. Global Benign Prostatic Hyperplasic Devices Market – Growth Strategy Analysis

Figure 21. Benign Prostatic Hyperplasic Devices Market Revenue Share, by Product (2022 and 2028)

Figure 22. Resectoscopes: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Urology Lasers: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Radiofrequency Ablation Devices: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Prostatic Stents: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Implants: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Benign Prostatic Hyperplasic Devices Market Revenue Share, by Procedure Type (2022 and 2028)

Figure 28. Transurethral Microwave Therapy: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Transurethral Resection of the Prostate: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Transurethral Needle Ablation of the Prostate: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Laser Surgery: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. UroLift Surgery: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Others: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Benign Prostatic Hyperplasic Devices Market Revenue Share, by End User (2022 and 2028)

Figure 35. Hospitals Market Revenue and Forecast to 2028 (US$ Million)

Figure 36. Clinics Market Revenue and Forecast to 2028 (US$ Million)

Figure 37. Ambulatory Surgical Centers Market Revenue and Forecast to 2028 (US$ Million)

Figure 38. Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 39. North America: Benign Prostatic Hyperplasic Devices Market, by Key Country – Revenue (2022) (US$ Million)

Figure 40. North America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 41. North America: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)

Figure 42. US: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43. Canada: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44. Mexico: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45. Europe: Benign Prostatic Hyperplasic Devices Market, by Key Country – Revenue (2022) (US$ Million)

Figure 46. Europe: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 47. Europe: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)

Figure 48. UK: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 49. Germany: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 50. France: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 51. Italy: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 52. Spain: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 53. Rest of Europe: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 54. Asia Pacific Benign Prostatic Hyperplasic Devices Market Overview, by Country (2021)

Figure 55. Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 56. Asia Pacific: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)

Figure 57. China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 58. Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 59. India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 60. South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 61. Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 62. Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 63. Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 64. Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 65. Middle East & Africa: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)

Figure 66. Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 67. South Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 68. UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 69. Rest of Middle East and Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 70. South and Central America Benign Prostatic Hyperplasic Devices Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 71. South and Central America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 72. South and Central America: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)

Figure 73. Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 74. Argentina Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 75. Rest of South and Central America: Benign Prostatic Hyperplasic Devices Market– Revenue and Forecast to 2028 (USD Mn)

Figure 76. Impact of COVID-19 Pandemic in North American Country Markets

Figure 77. Impact of COVID-19 Pandemic in European Country Markets

Figure 78. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 79. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 80. Impact Of COVID-19 Pandemic in South and Central America Country Markets

The List of Companies - Benign Prostatic Hyperplasic Devices Market

1. KARL STORZ SE & Co. KG

2. Richard Wolf GmbH

3. Olympus Corporation

4. Urologix, LLC.

5. Boston Scientific Corporation

6. Butterfly

7. TELEFLEX Incorporated

8. OmniGuide Holdings, Inc.

9. Convergent Laser Technologies

10. ProArc

11. Olympus Corporation

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the benign prostatic hyperplasic devices market.

● Highlights key business priorities in order to assist companies to realign their business strategies.

● The key findings and recommendations highlight crucial progressive industry trends in the global benign prostatic hyperplasic devices market, thereby allowing players across the value chain to develop effective long-term strategies.

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

● Scrutinize in-depth global market trends and outlook coupled with the factors driving the benign prostatic hyperplasic devices market, as well as those hindering it.

● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

TOP